These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7533379)

  • 1. Serum levels of pancreatic amylase and pancreas-specific protein as markers of pancreatic graft rejection episodes.
    Minakawa R; Brattström C; Tydén G; Tibell A; Pousette A; Bergström K
    Transplant Proc; 1995 Feb; 27(1):1329-30. PubMed ID: 7533379
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated pancreas rejection in combined kidney-pancreas transplantation: results of percutaneous pancreas biopsy.
    Klassen DK; Weir MR; Schweitzer EJ; Bartlett ST
    Transplant Proc; 1995 Feb; 27(1):1333-4. PubMed ID: 7533380
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel assay for pancreatic cellular damage: III. Use of a pancreas-specific protein as a marker of pancreatic graft dysfunction in humans.
    Fernstad R; Sköldefors H; Pousette A; Groth CG; Tydén G; Ost L; Lindholm A; Carlström K
    Pancreas; 1989; 4(1):44-52. PubMed ID: 2654929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation.
    Ploeg RJ; D'Alessandro AM; Groshek M; Gange SJ; Knechtle SJ; Stegall MD; Eckhoff DE; Pirsch JD; Sollinger HW; Belzer FO
    Transplant Proc; 1994 Apr; 26(2):531-3. PubMed ID: 7513455
    [No Abstract]   [Full Text] [Related]  

  • 5. Pancreas specific protein (PASP) monitoring in pancreas transplantation.
    Nyberg G; Olausson M; Nordén G; Mjörnstedt L; Blohmé I; Hedman L
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1604-5. PubMed ID: 1989305
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucose disappearance constant (KG) provides an alternative diagnostic marker of acute pancreas allograft rejection.
    Elmer DS; Hathaway DK; Shokouh-Amiri HM; Hughes TA; Gaber LW; Gaber AO
    Transplant Proc; 1994 Apr; 26(2):536. PubMed ID: 7513456
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical analysis of rejection markers sIL-2R, urinary amylase, and lipase in whole-organ pancreas transplantation with exocrine bladder drainage.
    Abendroth D; Capalbo M; Illner WD; Landgraf R; Land W
    Transplant Proc; 1992 Jun; 24(3):786-7. PubMed ID: 1376524
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of serologic and urinary tests with allograft biopsy in the diagnosis of pancreas rejection.
    Gill IS; Stratta RJ; Taylor RJ; Grune MT; Jerius JT; Sudan D; Radio SJ
    Transplant Proc; 1997; 29(1-2):673. PubMed ID: 9123474
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection.
    Grewal HP; Kotb M; Salem A; el Din AB; Novak K; Martin J; Gaber LW; Gaber AO
    Transplant Proc; 1993 Feb; 25(1 Pt 1):132-5. PubMed ID: 7679807
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of sequential fine-needle aspiration biopsy in the assessment of kidney and pancreas allograft rejection in dogs.
    Hawthorne WJ; Wilson TG; Greenberg MJ; Grierson JM; O'Neill P; Yung T; Earl MJ; Chapman JR; Little JM; Allen RD
    Transplant Proc; 1990 Oct; 22(5):2165-6. PubMed ID: 1699333
    [No Abstract]   [Full Text] [Related]  

  • 11. Markers for pancreatic allograft rejection: comparison of serum anodal trypsinogen, serum amylase, serum creatinine and urinary amylase.
    Douzdjian V; Cooper JL; Abecassis MM; Corry RJ
    Clin Transplant; 1994 Apr; 8(2 Pt 1):79-82. PubMed ID: 7517225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-monitoring serum anodal trypsinogen, serum amylase, and serum creatinine accurately differentiates rejection from other causes of allograft dysfunction after simultaneous pancreas-kidney transplantation.
    Lieberman JM; Marks WH; Stuart FP; Abecassis MM; Florence LS; Kauffman D
    Transplant Proc; 1997; 29(1-2):676-7. PubMed ID: 9123476
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum lipase as a marker for pancreatic allograft rejection.
    Sugitani A; Egidi MF; Gritsch HA; Corry RJ
    Clin Transplant; 1998 Jun; 12(3):224-7. PubMed ID: 9642514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel assay for pancreatic cellular damage: IV. Serum concentrations of pancreas-specific protein (PASP) in acute pancreatitis and other abdominal diseases.
    Fernstad R; Pousette A; Carlström K; Sköldefors H
    Pancreas; 1990; 5(1):42-9. PubMed ID: 1688389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection.
    Ploeg RJ; D'Alessandro AM; Groshek M; Gange SJ; Knechtle SJ; Stegall MD; Eckhoff DE; Pirsch JD; Sollinger HW; Belzer FO
    Transpl Int; 1994; 7 Suppl 1():S426-31. PubMed ID: 11271272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine levels predict the likelihood of rejection after simultaneous pancreas/kidney transplantation.
    Dawidson I; Lu C; Ar'Rajab A; Rossi P; Melone D; Wheeler D
    Transplant Proc; 1994 Apr; 26(2):534. PubMed ID: 8171540
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic renal allograft rejection can be predicted by the surface area under the serum creatinine versus time curve.
    Yilmaz S; Kallio E; Yilmaz A; Häyry P
    Transplant Proc; 1995 Feb; 27(1):927. PubMed ID: 7879233
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of rejection in simultaneous renal/pancreas (urinary bladder drained) transplantation.
    Dafoe DC; Campbell DA; Rocher L; Schwartz R; Turcotte JG
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2345-7. PubMed ID: 2484097
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of rejection after combined pancreas-kidney transplantation.
    Stratta RJ; Taylor RJ; Bynon JS; Lowell JA; Frisbie K; Brennan DC; Radio SJ; Cattral MS
    Transplant Proc; 1994 Apr; 26(2):524-5. PubMed ID: 8171536
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of pretransplant cytomegalovirus serology and treatment of rejection upon disease after kidney and kidney plus pancreas transplantation.
    Mayoral JL; Brayman KL; Gillingham KJ; Sutherland DE; Najarian JS; Dunn DL
    Transplant Proc; 1992 Jun; 24(3):929-31. PubMed ID: 1318594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.